Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Lakehead University

$25,000.00

Direct conversion medical imaging detector with Lead Oxide (PbO) x-ray-to-charge transducer.

FY 2019-20

Summary
X-ray imaging detectors rely on indirect or direct conversion of x-ray quanta to an electron signal, with the indirect method most commonly on commercial systems. In this case the multi-stage conversion process begins with a scintillator converting x-ray quanta into optical photons. The optical photons in turn diffuse through a phosphor and then are converted to electrons by an array of photodiodes. In the direct method, the x-ray quanta are absorbed in a photoconductor that directly creates electrical charge to generate an electron signal in the imaging array. The major advantage inherent in direct conversion is high spatial resolution. Recently, Reznik's group at Lakehead University synthesized a new photoconductor material for direct conversion x-ray imaging systems, called amorphous Lead Oxide (a-PbO), and demonstrated that a-PbO-based detectors have greater sensitivity at lower x-ray exposures. This has the core benefit to the imaging system designer of either reducing the incident x-ray dose to acquire a diagnostic image, and thereby improve the overall safety of general radiography and image-guided interventional procedures, or at typical x-ray exposures to improve image quality. Teledyne DALSA, a Canadian and a global leader in digital imaging products and solutions for medical and industrial imaging markets, recognizes the high potential of the application of a-PbO as an x-ray-to-charge transducer in the next generation of DALSA's direct conversion flat panel x-ray imaging detectors. However, a-PbO technology has to be improved before its unique imaging properties can be realized in commercial systems. Particularly, for use in DALSA's detectors, a-PbO technology has to be tailored to DALSA's product requirements. This demands the use of specialized material science and engineering approaches, which are the expertise of the Reznik's group. Dr. Reznik's group is well-positioned to solve this company-specific problem and to adjust a-PbO technology for applications in DALSA's direct conversion x-ray medical imaging detectors for low-dose real-time applications.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
541945-2019
Name nom
Reznik, Alla
Department département
Physics
Organization id
25
Institution établissement
Lakehead University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
2002
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials processing
Research subject fr
Transformation des matériaux
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Direct conversion medical imaging detector with Lead Oxide (PbO) x-ray-to-charge transducer.
Keyword
NSERC
Application summary
X-ray imaging detectors rely on indirect or direct conversion of x-ray quanta to an electron signal, with the indirect method most commonly on commercial systems. In this case the multi-stage conversion process begins with a scintillator converting x-ray quanta into optical photons. The optical photons in turn diffuse through a phosphor and then are converted to electrons by an array of photodiodes. In the direct method, the x-ray quanta are absorbed in a photoconductor that directly creates electrical charge to generate an electron signal in the imaging array. The major advantage inherent in direct conversion is high spatial resolution. Recently, Reznik's group at Lakehead University synthesized a new photoconductor material for direct conversion x-ray imaging systems, called amorphous Lead Oxide (a-PbO), and demonstrated that a-PbO-based detectors have greater sensitivity at lower x-ray exposures. This has the core benefit to the imaging system designer of either reducing the incident x-ray dose to acquire a diagnostic image, and thereby improve the overall safety of general radiography and image-guided interventional procedures, or at typical x-ray exposures to improve image quality. Teledyne DALSA, a Canadian and a global leader in digital imaging products and solutions for medical and industrial imaging markets, recognizes the high potential of the application of a-PbO as an x-ray-to-charge transducer in the next generation of DALSA's direct conversion flat panel x-ray imaging detectors. However, a-PbO technology has to be improved before its unique imaging properties can be realized in commercial systems. Particularly, for use in DALSA's detectors, a-PbO technology has to be tailored to DALSA's product requirements. This demands the use of specialized material science and engineering approaches, which are the expertise of the Reznik's group. Dr. Reznik's group is well-positioned to solve this company-specific problem and to adjust a-PbO technology for applications in DALSA's direct conversion x-ray medical imaging detectors for low-dose real-time applications.